Literature DB >> 33155307

Hepatitis B related dilemmas in the renal unit.

Stephen G Holt1,2, Stephen Locarnini3,4, Joe Sasadeusz2,3,5.   

Abstract

Testing for hepatitis B in dialysis patients is routine, but newer and more sensitive detection methods mean that there is sometimes confusion around viral loads and occult infection. There are frequently difficult choices surrounding isolation and treatment. Here we describe the use of HBV serology and DNA testing in decisions around patients with end-stage renal disease. We also suggest isolation decisions based on our current understanding of the virus and its infectivity.
© 2020 Asian Pacific Society of Nephrology.

Entities:  

Keywords:  clinical nephrology; end-stage kidney disease; haemodialysis; hepatitis B; infectious disease

Year:  2020        PMID： 33155307     DOI： 10.1111/nep.13815

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN： 1320-5358            Impact factor:   2.506


  2 in total

1.  An analysis of antibody responses and clinical sequalae of the Sinopharm HB02 COVID19 vaccine in dialysis patients in the United Arab Emirates.

Authors:  Stephen Geoffrey Holt; Sally Mahmoud; Wasim Ahmed; Juan Manuel Acuna; Ayman Kamal Al Madani; Islam Eltantawy; Walid Abbas Zaher; Gareth John Goodier; Nawal Ahmed Al Kaabi; Ali Abdulkareem Al Obaidli
Journal:  Nephrology (Carlton)       Date:  2021-10-05       Impact factor: 2.358

2.  Serological and molecular characterization of hepatitis B virus infection in chronic kidney disease patients from Rio de Janeiro, Brazil.

Authors:  Livia Melo Villar; Ketlyn Araujo Fraga; Ana Carolina da Fonseca Mendonça; Juliana Custódio Miguel; Elisangela Ferreira da Silva; Jakeline Ribeiro Barbosa; Paulo Sérgio Fonseca de Sousa; Lia Laura Lewis-Ximenez; Francisco Campello do Amaral Mello
Journal:  Braz J Infect Dis       Date:  2022-05-31       Impact factor: 3.257
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.